Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZBTB21 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | TRIM68 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | FAM26E | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | DARS | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | TRAM1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | GIGYF2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | ACP2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | THAP8 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | PYGB | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | ARPC2 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |